CMX-2043 is a promising biomedical product that functions as a potential therapeutic agent for cardiovascular diseases. It displays beneficial effects in treating heart failure, cardiac hypertrophy, and ischemic heart disease.
CAT No: R2008
CAS No: 910627-26-8
Synonyms/Alias: CMX-2043;(R)-Lip-L-glu-L-ala-OH;910627-26-8;Lip-ea;R-lip-ea-oh;83V80O4XY1;R-Lipoic acid-L-glutamate-L-alanine;UNII-83V80O4XY1;L-Alanine, N-(5-(3R)-1,2-dithiolan-3-yl-1-oxopentyl)-L-alpha-glutamyl-;alpha-N-((R )-1,2-Dithiolane-3-pentanoyl)-L-glutamyl-L-alanine;L-ALANINE, N-(5-(3R)-1,2-DITHIOLAN-3-YL-1-OXOPENTYL)-L-.ALPHA.-GLUTAMYL-;(4S)-4-(5-((3R)-DITHIOLAN-3-YL)PENTANOYLAMINO)-5-(((1S)-2-HYDROXY-1-METHYL-2-OXO-ETHYL)AMINO)-5-OXO-PENTANOIC ACID;(4S)-5-[[(1S)-1-carboxyethyl]amino]-4-[5-[(3R)-dithiolan-3-yl]pentanoylamino]-5-oxopentanoic acid;(4S)-4-(((1S)-1-carboxyethyl)carbamoyl)-4-(5-((3R)-1,2-dithiolan-3-yl)pentanamido)butanoic acid;(4S)-4-{[(1S)-1-carboxyethyl]carbamoyl}-4-{5-[(3R)-1,2-dithiolan-3-yl]pentanamido}butanoic acid;SCHEMBL9282164;CHEMBL3099551;AKOS040748162;DB12795;DA-72298;MS-26973;HY-119152;CS-0069067;NS00072095;Q27269454;.ALPHA.-N-((R )-1,2-DITHIOLANE-3-PENTANOYL)-L-GLUTAMYL-L-ALANINE;.ALPHA.-N-((R)-1,2-DITHIOLANE-3-PENTANOYL)-L-GLUTAMYL-L-ALANINE;ALPHA-N-((R)-1,2-DITHIOLANE-3-PENTANOYL)-L-GLUTAMYL-L-ALANINE;
Chemical Name: (4S)-5-[[(1S)-1-carboxyethyl]amino]-4-[5-[(3R)-dithiolan-3-yl]pentanoylamino]-5-oxopentanoic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C16H26N2O6S2 |
M.W/Mr. | 406.5 |
Sequence | One Letter Code:EA |
Appearance | Solid |
InChI | InChI=1S/C16H26N2O6S2/c1-10(16(23)24)17-15(22)12(6-7-14(20)21)18-13(19)5-3-2-4-11-8-9-25-26-11/h10-12H,2-9H2,1H3,(H,17,22)(H,18,19)(H,20,21)(H,23,24)/t10-,11+,12-/m0/s1 |
InChI Key | MQXRTCVZPIHBLD-TUAOUCFPSA-N |
Canonical SMILES | CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CCCCC1CCSS1 |
Isomeric SMILES | C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCCC[C@@H]1CCSS1 |
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.